1 hiv drug resistance training module 7: hiv genotyping assay validation

34
1 HIV Drug Resistance Training Module 7: HIV Genotyping Assay Validation

Upload: alexa-reeves

Post on 27-Mar-2015

277 views

Category:

Documents


3 download

TRANSCRIPT

Page 1: 1 HIV Drug Resistance Training Module 7: HIV Genotyping Assay Validation

1

HIV Drug Resistance Training

Module 7:

HIV Genotyping Assay Validation

Page 2: 1 HIV Drug Resistance Training Module 7: HIV Genotyping Assay Validation

2

Topics

Getting Ready to Validate Validation Concepts Validation Procedures

Page 3: 1 HIV Drug Resistance Training Module 7: HIV Genotyping Assay Validation

3

Objectives

Describe principles behind validation procedures.

Identify the procedures needed to gain confidence that the results are accurate and reproducible.

Given specific laboratory, customize procedures.

Page 4: 1 HIV Drug Resistance Training Module 7: HIV Genotyping Assay Validation

4

getting ready to validate

Why is it important to validate assays?What should you do to prepare for validation?When do you need to validate?

Page 5: 1 HIV Drug Resistance Training Module 7: HIV Genotyping Assay Validation

5

Validation of Genotyping Assay Performance

Helps ensure quality results Easier to compare results from labs using

different methods To establish performance characteristics

used to compare assays Required prior to testing any samples for

WHO Validation is assay-specific

– For instance, plasma vs. DBS sensitivity could be different, and extractions steps are not shared, so these methods should be validated separately.

Page 6: 1 HIV Drug Resistance Training Module 7: HIV Genotyping Assay Validation

6

Minimum Requirements

Minimal requirements for an assay validation to establish/confirm analytical performance characteristics:– Sensitivity– Specificity– Accuracy– Precision– Reproducibility

Page 7: 1 HIV Drug Resistance Training Module 7: HIV Genotyping Assay Validation

7

Preparation: Procedures

Standard Operating Procedures (SOPs) – For what?– How?

Quality control (QC) SOPs– For what?

Personnel?

Page 8: 1 HIV Drug Resistance Training Module 7: HIV Genotyping Assay Validation

8

Preparation: Validation Protocol

Written validation protocol finalized before results are analyzed– No changes to protocol allowed once validation

experiments started Determine acceptance criteria for each

section in advance Validation performed under the same

conditions (facility, equipment, reagents, personnel) that will be used for real samples

Page 9: 1 HIV Drug Resistance Training Module 7: HIV Genotyping Assay Validation

9

When to Repeat Validation Procedures

If there is failure to pass any criteria:– Document corrective action and re-validate– Do NOT simply repeat experiments with same

assay If procedure changes:

– Minor changes equivalency testing– Major changes re-validation for in-house

assays:• Primer modifications and replacement• Change RT and/or PCR enzymes

– See module 11, QA/QC

Page 10: 1 HIV Drug Resistance Training Module 7: HIV Genotyping Assay Validation

10

Discussion

Why is it important to validate assays? What should you do to prepare for

validation? When do you need to validate?

Page 11: 1 HIV Drug Resistance Training Module 7: HIV Genotyping Assay Validation

11

validation concepts

What criteria are we measuring against?

Page 12: 1 HIV Drug Resistance Training Module 7: HIV Genotyping Assay Validation

12

Components of Genotyping Assay Validation

Accuracy Precision/Reproducibility Sensitivity for RT-PCR amplification Sensitivity for detection of minority variants Specificity

Page 13: 1 HIV Drug Resistance Training Module 7: HIV Genotyping Assay Validation

13

Accuracy Definition

Are “known” mutations detected?

Page 14: 1 HIV Drug Resistance Training Module 7: HIV Genotyping Assay Validation

14

Accurate Inaccurate

Accuracy: How close do we get to the expected (target) value or result.

Page 15: 1 HIV Drug Resistance Training Module 7: HIV Genotyping Assay Validation

15

Accuracy Discussion

Best tested using: – clonal virus or lab constructs (e.g. site-directed

mutants)– very well-characterized, non-clonal sample (e.g.

artificial 50/50 mixtures of clones) Test for:

– “Resistance-associated” mutations– Likely to be frequently encountered

Pro: Usually the easy to measure Con: Difficult to define criteria ahead of

time for very new assays

Page 16: 1 HIV Drug Resistance Training Module 7: HIV Genotyping Assay Validation

16

Precision Definition

Ability to generate the same result on multiple aliquots of the same sample within a test run (intra-assay variability) – Fewer samples (e.g. 3 to 5), more replicates

(e.g. 5 to 10)

Page 17: 1 HIV Drug Resistance Training Module 7: HIV Genotyping Assay Validation

17

Precise(although inaccurate!)

Imprecise(although sometimes accurate)

Precision: How close are all the results to each other?

Page 18: 1 HIV Drug Resistance Training Module 7: HIV Genotyping Assay Validation

18

Accuracy and Precision

The degree of fluctuation in the measurements is indicative of the “precision” of the assay.

The closeness of measurements to the true value is indicative of the “accuracy” of the assay.

Quality Control is used to monitor both the precision and the accuracy of the assay in order to provide reliable results.

Page 19: 1 HIV Drug Resistance Training Module 7: HIV Genotyping Assay Validation

19

Precise: NoAccurate: No

Accuracy and Precision

Precise: YesAccurate: No

Precise: YesAccurate: Yes

Page 20: 1 HIV Drug Resistance Training Module 7: HIV Genotyping Assay Validation

20

Reproducibility

Ability to generate the same result on multiple aliquots of the same sample in different test runs (inter-assay variability)– More samples (e.g. up to 40), fewer replicates (2

or 3)– Over time (e.g. 2 weeks)– Between operators– Among lots of critical reagents

Page 21: 1 HIV Drug Resistance Training Module 7: HIV Genotyping Assay Validation

21

Reproducibility: When conditions change, how does that affect the

results?

Page 22: 1 HIV Drug Resistance Training Module 7: HIV Genotyping Assay Validation

22

Reproducibility and Precision Criteria

Based on nucleotide sequence identity in:– Pairwise comparisons or– Comparison to a consensus sequence

Mismatches may be considered a difference (if “compatible” e.g. A and R, or R and D, but not A and Y, or M and K)– Acceptance criteria may depend on complexity

of samples tested Based on amino acid sequence identity

– “resistance-associated” mutations can be analyzed separately

Page 23: 1 HIV Drug Resistance Training Module 7: HIV Genotyping Assay Validation

23

Critical Reagent Lot-to-lot Variability is a Component of Assay Reproducibility

Reagent vendors test products (e.g. PCR enzymes) using procedures different from HIVDR genotyping

Cannot assume that performance is the same, between lots

Incorporate at least 2 lots of critical reagents in validation experiments

Perform lot-release testing as part of routine QC (see module 11)

Page 24: 1 HIV Drug Resistance Training Module 7: HIV Genotyping Assay Validation

24

Sensitivity: Amplification

Definition: What is the minimum viral load required to generate an accurate result?

Considerations:– Importance placed on multiple subtypes varies

with intended application– Overlaps with linearity if samples also

genotyped and sequences compared – May or may not involve probing multiple variant

detection (mixtures) at low VL

Page 25: 1 HIV Drug Resistance Training Module 7: HIV Genotyping Assay Validation

25

Sensitivity: Detection of Minority Variants

In samples with mixtures What % of the pool must minor variant be

in order to be reliably detected?– Can separate out post-amplification steps (e.g.

by mixing plasmids and sequencing vs. mixing viruses and amplifying then sequencing)

– In reality, affected by viral load, though this is not often highlighted

Page 26: 1 HIV Drug Resistance Training Module 7: HIV Genotyping Assay Validation

26

Dependence of Sensitivity of Detection of Minor Variants and Input Viral Load

Assume that 200 µl plasma used for RNA extraction, 25% used for RT-PCR; RT successful for 20% of RNA molecules; minority variant present at 10% of total

Viral load (copies/ml)

RNA copies in RT rxn

Amplifiable genomes

Copy no. (minor variant)

100,000 5,000 1000 100

10,000 500 100 10

1000 50 10 1

Page 27: 1 HIV Drug Resistance Training Module 7: HIV Genotyping Assay Validation

27

Discussion

What criteria are we measuring against?

Page 28: 1 HIV Drug Resistance Training Module 7: HIV Genotyping Assay Validation

28

validation procedures

How can we set up validation procedures for our lab?

Page 29: 1 HIV Drug Resistance Training Module 7: HIV Genotyping Assay Validation

29

Validation Criteria (Example)

Accuracy– 100% of known mutations must be detected

Precision/Reproducibility– ≥ 90% of pairwise comparisons must be at least

98% identical, mixtures counted as difference Sensitivity for amplification

– ≥ 95% of samples with viral loads between 500 and 1000 copies/ml must be amplified and successfully genotyped (n ≥ 10)

Sensitivity for detection of minority variants– defined as the lowest % at which a mutation is

detected in > 50% of replicate tests

Page 30: 1 HIV Drug Resistance Training Module 7: HIV Genotyping Assay Validation

30

Specimen Selection

Specimens used in the validation experiments should be chosen to test the specific aspect of assay performance (accuracy, reproducibility, etc.)

Especially for precision and reproducibility, chose specimens that are similar to those that will be tested routinely (i.e. specimen type, genetic subtype, viral load range)

Specimens should be well-characterized in pre-validation experiments before starting the actual validation

Page 31: 1 HIV Drug Resistance Training Module 7: HIV Genotyping Assay Validation

31

Validation Procedure Customization

Details of the variables to be considered are likely to be different in each lab– Physical set-up– Personnel (number of qualified analysts)– Degree of automation

Validation protocols can be reviewed in consultation with other accredited labs or with WHO staff

Page 32: 1 HIV Drug Resistance Training Module 7: HIV Genotyping Assay Validation

32

Discussion

How can we set up validation procedures for our lab?

Page 33: 1 HIV Drug Resistance Training Module 7: HIV Genotyping Assay Validation

33

Reflection

What do we need to do to make sure we are correctly validating our assays?

Page 34: 1 HIV Drug Resistance Training Module 7: HIV Genotyping Assay Validation

34

Summary

Getting Ready to Validate Validation Concepts Validation Procedures